Journal of Natural Products · 2008 · 89 citations · 22 references
MedicineOncologyPharmacologyBiochemical PharmacologyCancer PharmacologyDrug DiscoveryAroma CompoundsCancer ChemopreventionEnzyme InhibitionMetabolite IdentificationOncology PharmacologyAromatase InhibitionAromatase InhibitorsBioactive ConstituentsBreast Cancer ChemopreventionHerbal SupplementsMicrosomal Enzyme ActivityPhytochemicals In Cancer Prevention
Twelve xanthone constituents of the botanical dietary supplement mangosteen (the pericarp of Garcinia mangostana) were screened using a noncellular, enzyme-based microsomal aromatase inhibition assay. Of these compounds, garcinone D (3), garcinone E (5), alpha-mangostin (8), and gamma-mangostin (9) exhibited dose-dependent inhibitory activity. In a follow-up cell-based assay using SK-BR-3 breast cancer cells that express high levels of aromatase, the most potent of these four xanthones was gamma-mangostin (9). Because xanthones may be consumed in substantial amounts from commercially available mangosteen products, the consequences of frequent intake of mangosteen botanical dietary supplements require further investigation to determine their possible role in breast cancer chemoprevention.
22
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text